LYCOAT. New solutions for Film Coating from Roquette. LYCOAT for quicker quality coating

Similar documents
ORAL DOSAGE OVERVIEW

Easy, fast and reliable!

Easy, fast and reliable!

REVISION OF MONOGRAPH ON TABLETS. Tablets

Dow Wolff Cellulosics. Using ingenuity and savvy. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

EXPANDING WHAT S POSSIBLE WITH THE RIGHT PARTNER. Life-saving pharmaceuticals start with high-quality ingredients

SUMMARY AND CONCLUSION

innovative products. faster to market. reliably supplied.

Excipient Considerations for Continuous Manufacturing Implementation

The solid choice for Omega-3

Critical material properties for the design of robust drug products : excipient functionality related characteristics

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy

innovative products. faster to market. reliably supplied.

CHEWABLE SOFTGEL TECHNOLOGY

Challenges in Developing Stable and Efficient Probiotic Formulations

Designed and manufactured specifically for pharmaceutical capsule filling

Folic Acid in Human Nutrition

Development of USP Delayed Release Aspirin Tablets using Opadry Enteric, Acrylic-Based Coating System

Kollicoat Smartseal 30 D Active Protection

Differentiate your brand. with the unique look and performance of capsugel s press-fit and xpress-fit gelcaps. capsugel.com

CONSIDERATION OF THE END USER AND THE LIMITATIONS DURING THE ORAL ADMINISTRATION DRUG DESIGN: CHALLENGE IN DIFFERENT AGE GROUPS

GLYCOLYS

In-Vitro Bioequivalence Studies for Oral Solid Dose products using the Morphologi G3-ID

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)

A matter of timing. ensure optimal delivery for acid-sensitive products. capsugel.com

Food supplement manufacture

Direct Compression Formulation Using Starch 1500 with Ranitidine HCl (150 mg) Tablets, Film Coated with Opadry II (85F Series)

Leader in custom manufacturing. for the pharmaceutical and nutraceutical industries.

REGULATORY PERSPECTIVE. Dr. Raghunandan H V Associate Professor JSSCP, JSSU, Mysore

Advanced functional coating solutions for nutraceuticals

Excipients make the difference! Dr. Felicitas Guth Global Technical Service Excipients Pharma Ingredients & Services BASF SE

TECHNICAL INFORMATION RxCIPIENTS FM A versatile excipient for orally disintegrating tablet (ODT) formulations

Partner with the Global Leader in Drug Delivery Systems

Ion Exchange Resins. Unique Solutions to Formulation Problems

PHARMACEUTICAL TECHNOLOGY REPORT. Abstract Summary. Introduction. Experimental Methods. Consumer Specialties ashland.com

SCIENTIFIC DISCUSSION. Antimycobacterial (J04AC01).

The right impact on taste and texture CONDITIONING COATING BROCHURE

ExcipientFest Americas 2013 SHELLAC. A Versatile Film Coating System

AnyCoat. From Nature, Beside you.

Soluplus The Solid Solution Opening New Doors in Solubilization.

Hydrodynamic Robustness of Hypromellose and Methylcellulose Based Modified Release Matrix Systems D. Tewari, R. K. Lewis, W. W. Harcum and T Dürig

FLAVOUR FLOW & ADHESION

New formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability

SCIENTIFIC DISCUSSION. Efavirenz

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

SCIENTIFIC DISCUSSION

SCIENTIFIC DISCUSSION

METOLOSE: CONTENTS PAGE

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

Nutrition. Beauty & Vitality designers. Ingredients that inspire

Protection and Processing of a Highly Hygroscopic Herbal Extract by Drug Layering and Film Coating

Unigel TM Case Study: Extending Soft Gelatin Capsule Benefits to Novel Fixed Dose Combinations

SCIENTIFIC DISCUSSION. AkuriT-3 Tablets*

Mylan Laboratories Limited F-4 & F-12, Malegaon MIDC, Sinnar Nashik Maharashtra State, India

Advanced functional coating solutions for nutraceuticals

Comparison - Aqueous vs. Solvent based Ethylcellulose Films. H.S. Hall, K.D. Lillie & R.E. Pondell

Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose

PINOVA ESTER GUM 8BG STABILITY. SAFETY. SUSTAINABILITY.

The binding performance of DFE Pharma Starch

Connect with consumers for life. Introducing new MEG-3 Ultra and life sdha Ultra

SCIENTIFIC DISCUSSION

Granulation SyStEmS For waxes & oleochemicals

FROM SOLVENT TO AQUEOUS COATINGS. (Out of the Frying Pan...) Ralph E. Pondell. Coating Place, Inc. P.O. Box

Study of Consumer Preferences: Solid Oral Dosage Forms. Pharmaceutical n OTC n Dietary Supplement

Innovations in Design: NIA-West. Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017

DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE

The Nutraceutical Solutions! CERTIFIED ISO

SOFT GELATIN CAPSULE. Dr. Nawal Ayash

SCIENTIFIC DISCUSSION

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LIQUID PREPARATIONS FOR ORAL USE

Your partner in CAPS & CLOSURES. Polyolefins the material of choice for caps & closures.

Consumer Health Care V5.0_2013

WE VE GOT THE POWDER THE KEY TO YOUR NEW MEDICATED CHEWING GUM

Formulation factors affecting acceptability of oral medicines in children

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process

Challenges and solutions for moisture sensitive API formulation

The Soft Gel Specialist

Public Assessment Report. Scientific discussion. Venlafaxin SUN 37.5 mg, 75 mg and 150 mg prolonged-release tablets. (venlafaxine hydrochloride)

Savesta Herbals is engaged in manufacturing

CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION

Table 1. Coating Parameters

Formulation and evaluation of fast dissolving tablet of aceclofenac

Q&A for submission of applications for prequalification of Zinc Sulfate tablets and Zinc Sulfate oral liquid (solution)

Novel Ingredient Solutions for Removing Weighting Agents

GLOBAL SPECIALTY INGREDIENTS (M) SDN BHD ( M)

Novel low-calorie bulk sweeteners

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

SCIENTIFIC DISCUSSION

DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa, NJ

HARD TWO-PIECE HPMC CAPSULES FOR PHARMACEUTICAL APPLICATIONS IN INHALATION

SCIENTIFIC DISCUSSION

Because you want to achieve your best possible health

Formulation and evaluation of oral dispersible tablets of aripiprazole

The Effect of Film Coating and Storage Conditions on the Performance of Metformin HCl 500 mg Extended Release Hypromellose Matrices

Public Assessment Report. Scientific discussion. Diliban Retard Tramadol/Paracetamol IS/H/0168/001/DC. Date:

EUDRAGIT E 100, EUDRAGIT E PO and

Transcription:

LYCOAT New solutions for Film Coating from Roquette LYCOAT for quicker quality coating

Roquette LYCOAT New solutions for Film Coating from Roquette LYCOAT New solutions for Film Coating Film coating, the ultimate must Film coating is widely used by the Pharmaceutical industry for aesthetic or functional purposes. Coated tablets and capsules offer benefits for both patient and laboratory. For patients, coated tablets mean a more attractive appearance, simpler identification, enhanced taste and odour, and easier swallowing. In the laboratory, film coating helps identify brands, prevents cross-contamination, improves packaging efficiency, and protects from light, water and gases. Limitation of existing polymers There are many polymers on the market for aqueous film coating. Modified celluloses are the most widely used, although they have drawbacks such as: Poor organoleptic ( mouth-feel ) properties: strong taste, odour and yellow colour of the suspension, plus black spots in the product due to the drying process. Bad solubilisation, due to foam and lump formation during suspension preparation. High cost due to polymer costs and a long processing time. Demand for more functional coating solutions is growing. It takes outstanding innovation and proven commitment to deliver them: Roquette s new LYCOAT range is a major breakthrough in aqueous film coating. LYCOAT range LYCOAT is Roquette s latest innovation in the pharmaceutical field. It is a modified starch specifically developed for aqueous film coating for immediate release, solid oral dosage forms. LYCOAT is available in two viscosity grades: LYCOAT RS 78, developing lower viscosity LYCOAT RS 72, developing higher viscosity Viscosity (mpa.s) 14 HPMC 12 LYCOAT RS 78 1 LYCOAT RS 72 8 6 4 2 1 15 2 25 Dry substance (%) Viscosity as a function of dry substance

Coating process: simple, quick and efficient Preparation at its simplest With LYCOAT you don t have to worry about lump and foam formation. It dissolves completely and very rapidly at room temperature using traditional mixing equipment. LYCOAT suspensions are absolutely neutral. Film coatings applied with such suspensions will not impair either the flavour or the colour of tablets. Dispersion comparison of LYCOAT (left) with granulated HPMC (right, top) and traditional HPMC (right, bottom) When low viscosity means substantial cost savings Suspension s viscosity is key to the success of a coating process because it impacts directly on: The dry substance of the suspension and hence the coating time Spraying uniformity and hence coating quality. Even at high solid content, spraying is uniform. As temperature increases, LYCOAT viscosity decreases, whereas HPMC gels from 6 C upwards. Bearding has not been observed with LYCOAT. There is therefore no need to stop the coating process for cleaning operations or to use specific anti-bearding guns. Viscosity (mpa.s) 35 3 25 2 15 1 5 2 LYCOAT (25%) HPMC 6mPa.s (1%) 3 4 5 6 7 75 Temperature ( C) Viscosity as a function of temperature (Rheometer physica MCR 31) Cut process costs thanks to quick coating 3% weight gain For aesthetic coatings, a 3% polymer deposit is often considered sufficient. With LYCOAT this is achieved in about 3 minutes, whereas about 6 minutes are necessary with HPMC. Coating costs are dramatically reduced thanks to: Minimized coating time No production stops for gun cleaning. LYCOAT 3% weight gain HPMC 1 2 32 4 5 6 7 72 Coating time (min) A shorter coating time with LYCOAT RS 78 than HPMC

Coating performances: great, glossy and high quality ph-independent disintegration time Disintegration time is not significantly altered by LYCOAT coating, whatever the ph of the media: water, gastric (ph=2.) or intestinal (ph= 8.). Whatever the ph, the API solubilisation is therefore not affected by LYCOAT coating, - a basic requirement for nonfunctional coating. Disintegration time (s) 2 18 16 14 12 1 8 6 4 2 LYCOAT coated tablet Core tablet gastric neutral intestinal Disintegration time at different ph A brilliant appearance Tablets coated with LYCOAT have a very attractive finish. Colour is uniform; the surface is very smooth and the tablets overall very glossy. When tablet glossiness was measured at different light reflection angles, LYCOAT -coated tablets were glossier than HPMC-coated tablets. At a 3% weight deposit no infilling nor bridging of logos and intagliations was observed with LYCOAT coating. Glossiness (%) 25 2 15 1 5 2 LYCOAT HPMC 3 4 5 6 7 8 9 Light reflection angle ( ) Comparative tablet glossiness Film robustness means tablet strength The LYCOAT films on the tablets has been shown to withstand severe conditions. Friability remains nil. No edge chipping has been observed for LYCOAT coated tablets, when using the EP Pharmacopoeia friability test. LYCOAT casted films appeared to be more resistant to deformation and stress, as their resistance before rupture and their elongation are higher. LYCOAT coated tablets, stored at 4 C and 75% RH, naked or in HDPE jars, exhibited a good stability. LYCOAT films also have barrier properties.

Roquette LYCOAT New solutions for Film Coating from Roquette LYCOAT at a glance........................ For quicker quality coating! A bland polymer.............................. Leaving all the doors open for your formulations Very easy to prepare.......................... No worries with lumps and foam A low viscosity at high dry substance........ Shortens your coating time (and time is money ) A high quality coating........................ For your high quality product Excellent film properties..................... Proven to withstand stress Unimpaired tablet properties................ That s the minimum requested Brilliant tablet appearance................... That will dazzle you Regulatory status LYCOAT s food regulatory status makes it an ideal polymer for nutraceutical film coatings Compliance with the European directive on food additives (E144) Compliance with the 21 CFR and FCC. Pharmaceutical regulatory status of LYCOAT Compliance with the EP starch, hydroxypropyl, pregelatinised starch monograph (2645) Compliance with the USP/NF pregelatinized hydroxypropyl pea starch monograph

N Roquette LYCOAT New solutions for Film Coating from Roquette Is your film coating as good as you think it is? LYCOAT for quicker quality coating Demand for more functional tableting solutions is growing. It takes outstanding innovation and proven commitment to deliver them. Roquette LYCOAT is a major breakthrough in aqueous film coating. Dramatically reduced coating times mean significant cost savings. Lump- and foam-free suspensions come easily. And excellent mechanical properties, high gloss and true smoothness with no logo-bridging guarantee unbeatable quality, every time. Thinking film coating? Think LYCOAT. Pharmaceutical and Cosmetic Business Unit ROQUETTE Frères 628 Lestrem Cedex France Tel: 33 ()3 21 63 36 Fax: 33()3 21 63 94 64 pharma.business.unit@roquette.com www.roquettepharma.com Registered trademark of the company Roquette Frères - Roquette Frères S.A. / D3C - 9 /213 The information in this technical bulletin is to the best of our knowledge true and accurate but all instructions, recommendations or suggestions are made without any guarantee. Furthermore, no liability is accepted if use of any product in accordance with these data or suggestions infringes any patent.